Literature DB >> 1743245

Treatment of insomnia with two benzodiazepines: a double-blind crossover study.

K G Götestam1, F Oppöyen, D Berntzen.   

Abstract

Twenty-eight patients (12 M, 16 F) with insomnia were treated with nitrazepam 5 mg/d and oxazepam 25 mg/d, each for 11 days, in a double-blind crossover comparison with placebo. Half the patients received nitrazepam in the first drug period, and oxazepam in the second and the other half followed the contrary sequence. Both nitrazepam and oxazepam were found to be effective in inducing sleep and increasing sleep quality. No effects on dreaming or adverse effects were found. Nitrazepam did influence the frequency of awakening, but only in the second drug period. In the first period it reduced self-waking. It is concluded that both nitrazepam and oxazepam were effective in inducing sleep and in improving sleep quality.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743245     DOI: 10.1007/BF00265906

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  The effect of a new benzodiazepine on the polygraphically monitored sleep of normal volunteers.

Authors:  F R Freemon; M S Al-Marashi; J C Lee
Journal:  J Clin Pharmacol       Date:  1977-07       Impact factor: 3.126

2.  The effect of oxazepam on sleep in normal human volunteers.

Authors:  W Lehmann
Journal:  Acta Psychiatr Scand Suppl       Date:  1978

3.  Prevalence of sleep disturbance in a primarily urban Florida County.

Authors:  I Karacan; J I Thornby; M Anch; C E Holzer; G J Warheit; J J Schwab; R L Williams
Journal:  Soc Sci Med       Date:  1976-05       Impact factor: 4.634

4.  Comparative effectiveness of nine hypnotic drugs: sleep laboratory studies.

Authors:  A Kales; E O Bixler; J D Kales; M B Scharf
Journal:  J Clin Pharmacol       Date:  1977-04       Impact factor: 3.126

Review 5.  Hypnotics. Their place in therapeutics.

Authors:  A N Nicholson
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

6.  New hypnotic agents: clinical studies in general practice.

Authors:  D Wheatley
Journal:  Pharmacol Biochem Behav       Date:  1988-04       Impact factor: 3.533

7.  Prevalence of sleep disorders in the Los Angeles metropolitan area.

Authors:  E O Bixler; A Kales; C R Soldatos; J D Kales; S Healey
Journal:  Am J Psychiatry       Date:  1979-10       Impact factor: 18.112

8.  Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo.

Authors:  D A Hegelbach-Feller; J M Tschopp; S Christeller; J Fabre
Journal:  Arzneimittelforschung       Date:  1988-03

9.  Insomnia and its treatment. Prevalence and correlates.

Authors:  G D Mellinger; M B Balter; E H Uhlenhuth
Journal:  Arch Gen Psychiatry       Date:  1985-03

Review 10.  Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.

Authors:  S I Ankier; K L Goa
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

View more
  3 in total

1.  Meta-analysis of benzodiazepine use in the treatment of insomnia.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

2.  Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Michael J Sateia; Daniel J Buysse; Andrew D Krystal; David N Neubauer; Jonathan L Heald
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

Review 3.  The pharmacologic management of insomnia in patients with HIV.

Authors:  Toma S Omonuwa; Harold W Goforth; Xavier Preud'homme; Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.